TCM Pharma ApS

TCM Pharma ApS (CVR number: 39022508) is a company from VESTHIMMERLANDS. The company recorded a gross profit of 223.3 kDKK in 2023. The operating profit was 174.6 kDKK, while net earnings were 136.4 kDKK. The profitability of the company measured by Return on Assets (ROA) was 20.2 %, which can be considered excellent and Return on Equity (ROE) was 27.4 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 10.6 %, a level that can be considered to be very low. This means the company is highly leveraged, with most assets financed through debt. This high level of financial risk could pose challenges in periods of financial distress or rising interest rates. TCM Pharma ApS's liquidity measured by quick ratio was 0 which is at a very low level. Thus, the company is in an unstable financial position, with its liquid assets significantly undermatching its current liabilities. This severe liquidity deficiency may lead to financial distress and threaten the company's operational continuity.